Buenas noticias para las pacientes con cáncer de mama precoz con alto riesgo de recaída
Only La Razón reports this: no contrast yet
None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.
Demuestran un beneficio clínicamente relevante en la supervivencia global al usar ribociclib más terapia endocrina
Capture record
- Source
- https://www.larazon.es/salud/buenas-noticias-pacientes-cancer-mama-precoz-alto-riesgo-recaida_202610236adb5ed3f655b65cc3864473.html
- Published
- 23/10/2026 13:19 UTC
- Captured
- 23/10/2026 13:25 UTC
- Text fingerprint
3784b9743c2483a3· 980 words- Changes detected
- 0
- Archived copy
- Wayback Machine ↗